Hofseth BioCare Balance Sheet Health
Financial Health criteria checks 2/6
Hofseth BioCare has a total shareholder equity of NOK155.7M and total debt of NOK162.6M, which brings its debt-to-equity ratio to 104.4%. Its total assets and total liabilities are NOK390.7M and NOK235.0M respectively.
Key information
104.4%
Debt to equity ratio
NOK 162.59m
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 22.16m |
| Equity | NOK 155.67m |
| Total liabilities | NOK 235.05m |
| Total assets | NOK 390.71m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0Q6H's short term assets (NOK138.7M) do not cover its short term liabilities (NOK139.7M).
Long Term Liabilities: 0Q6H's short term assets (NOK138.7M) exceed its long term liabilities (NOK95.3M).
Debt to Equity History and Analysis
Debt Level: 0Q6H's net debt to equity ratio (90.2%) is considered high.
Reducing Debt: 0Q6H's debt to equity ratio has reduced from 188.3% to 104.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0Q6H has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0Q6H has less than a year of cash runway if free cash flow continues to grow at historical rates of 2% each year.